Bandi Laboratories Ltd.
13074210
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2024
micro entity
Next accounts due
30/09/2026
Confirmation statement
Last: 11/06/2026
Due 25/06/2027
Industry
Officers
Ms Sylwia Elzbieta Krukiewicz-Ledochowski
director · Since 09/12/2020
DIRECTOR
POLISH · UNITED KINGDOM · Age 53
Persons with Significant Control
Mr Michal Kicinski
Polish · Poland · Age 48
Ealing Cross, 1st Floor, London, W5 5TH
Notified 11/06/2021
Former PSCs
Ms Sylwia Krukiewicz-Ledochowski
Ceased 11/06/2021
Ms Sylwia Elzbieta Krukiewicz-Ledochowski
Ceased 11/06/2021
CompanyRankvs 2938+ SIC 46190 peers61
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£17k
Balance sheet strength
Cash
£30k
Cash in the bank
Net Current Assets
£26k
Working capital
Current Assets
£30k
Current Liabilities
£4k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 6.73 | +£7k |
| 2024 | 1.94 | — |
| 2023 | 3.04 | — |
Derived from filed accounts. Not audited figures.